Questcor Pharmaceuticals (QCOR)
News
| May 31 | RT @BioDueDiligence $AMRN I'm gonna ask the $arna director who sold under 2 bucks the same question or Don Bailey over at $QCOR why so low by ITradeforMe |
| May 31 | $QCOR finds support at the 50-day line. by DarvasTrader |
| May 31 | $MDVN was streetsweeper the same people that hit $QCOR? Nothing became of it. by nomelake |
| May 30 | $QCOR hearing that borrowing cost is up to 6-7% and climbing. http://stks.co/42UM by s55amg |
| May 30 | $QCOR staying abv. rout. So this is how stck. buy backs help. by Ibdinv |
| May 30 | $AMRN Green Bio's $qcor $thld $arna $VTUS Catalysts trump Europe by ITradeforMe |
| May 29 | 6 Mid Cap Healthcare Stocks Ready For Growth With Cash On Hand |
| May 29 | Stock Futures Track Europe's Gains; Titan Rises |
| May 29 | 9 Profitable Biotechnology Stocks With Plenty Of Cash |
| May 26 | IBD 50's Top 5 Medical Stocks Healthy In Sick Market |
| May 25 | Insiders Buying Shares In These 3 High-Growth Drug Stocks, Plus 2 Other Noteworthy Se... |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Biotechnology
Questcor Pharmaceuticals, Inc. produces, markets and sells prescription drugs. Its products include H.P. Acthar Gel (Acthar) and Doral. Acthar is an injectable drug for the treatment of the following indications: acute exacerbations of multiple sclerosis in adults; nephrotic syndrome; and infantile spasms in infants and children under two years of age. Doral is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings and/or early morning awakenings. Questcor Pharmaceuticals was founded on November 17, 1999 and is headquartered in Anaheim, California.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Questcor Pharmaceuticals is up 79.76% over the last year vs S&P 500 Total Return up 0.88%, Alexion Pharmaceuticals up 91.00%, and Amgen up 17.25%.
- QCOR Total Returns
- ^SPXTR Total Returns
- ALXN Total Returns
- AMGN Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these QCOR related companies
Pro Strategies Featuring QCOR
Did Questcor Pharmaceuticals make it into our Pro Portfolio Strategies?
QCOR Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other QCOR Resources
- Company Website
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| QCOR | 41.40 | -0.16 | -0.39% | 2.643B |
| QCOM | 57.31 | -0.14 | -0.24% | 97.17B |
| QCCO | 4.090 | -0.00 | -0.00% | 70.51M |
| QBC | 0.27 | -0.03 | -10.00% | 23.05M |
| QBAK | 1.94 | +0.00 | +0.00% | 23.76M |
| QAI | 27.30 | +0.07 | +0.26% | |
| PW | 8.95 | +0.25 | +2.87% | 14.09M |
| PVTB | 14.73 | -0.08 | -0.54% | 1.073B |
| PVSW | 7.10 | +0.18 | +2.60% | 111.97M |
| PVR | 23.21 | +0.06 | +0.26% | 1.830B |
